Close

Allergan (AGN) Affirms Receipt of FDA Committee Backing for Desmopressin Nasal Spray NDA

Go back to Allergan (AGN) Affirms Receipt of FDA Committee Backing for Desmopressin Nasal Spray NDA

Allergan (AGN) Wins FDA Panel Backing For Nocturia Treatment - Bloomberg

October 19, 2016 3:54 PM EDT

Allergan (NYSE: AGN) Wins FDA Panel Backing For Nocturia Treatment - Bloomberg

... More